1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Chr. Hansen Holding A/S
  6. Company
    CHR   DK0060227585

CHR. HANSEN HOLDING A/S

(CHR)
  Report
Real-time Estimate Cboe Europe  -  03:32 2022-08-17 am EDT
480.50 DKK   +0.97%
08/02Chr. Hansen Holding A/S - Major shareholder announcement from APG Asset Management N.V.
GL
08/02Chr. Hansen Holding A/S - Major shareholder announcement from APG Asset Management N.V.
GL
07/07European shares march higher on auto, commodity boost
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Chr. Hansen Holding A/S specializes in the development, production and marketing of biotechnological ingredients for the food processing, animal feed and health industries. Net sales (excluding activities being sold) break down by family of products as follows:

- cultivations and enzymes (65%);

- medical and nutritional ingredients (35%): used in the manufacturing of dietary supplements, OTC drugs, baby products and animal feed.

Net sales (excluding activities being sold) are distributed geographically as follows: Denmark (1%), Europe/Middle East/Africa (38%), the United States (28%), North America (2.9%), Asia/Pacific (18.1%) and Latin America (12%).
Sales per Business
20202021Delta
Food Cultures & Enzymes5 172.8071.5%5 210.9365% +0.74%
Health & Nutrition2 066.5828.5%2 803.7135% +35.67%
DKK in Million
Sales per region
20202021Delta
EMEA2 983.8241.2%3 125.8239% +4.76%
North America2 135.2429.5%2 476.4030.9% +15.98%
Asia Pacific1 227.7117%1 450.5818.1% +18.15%
Latin America892.6112.3%961.8512% +7.76%
DKK in Million
Managers
Name Title Age Since
Mauricio Graber President & Chief Executive Officer 59 -
Lise Mortensen Chief Financial Officer & Executive Vice President 53 2020
Henrik Joerck Nielsen Chief Scientific Officer & Executive VP - 2022
Torsten Steenholt Executive Vice President-Global Operations 52 2017
Winnie Hojvang BŘgel Vice President-Compliance & Corporate Affairs 56 -
Anders Mohr Christensen Vice President-Group Strategy & Investor Relations - -
Helle Rexen Consultant & Communications Partner - 2015
Christoffer Lorenzen Executive Vice President-Food Cultures & Enzymes 46 2018
Klaus Stegler Bjerrum Executive Vice President-Natural Colors Division 52 2018
Anne Reker Cordt Vice President-Strategy & Business Development 42 2018
Members of the board
Name Title Age Since
Dominique Reiniche Chairman 67 2018
Luis Cantarell Rocamora Independent Director 69 2016
Jesper Brandgaard Vice Chairman 58 2018
Heidi Kleinbach-Sauter, Dr. Independent Director 65 2017
Lise Kaae L÷vbjerg Independent Director 52 2020
Kevin Michael Lane Independent Director 56 2020
Charlotte Hemmingsen Non-Independent Director 57 2017
Kim L. B. S°rensen, Dr. Non-Independent Director 58 2017
Casper Lynghoej Giedo Director 39 2021
Karen Lauesen Director 44 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 131,926,268 102,671,024 77.8% 182,523 0.1% 77.8%
Shareholders
NameEquities%
Novo Holdings A/S (Investment Company) 28,983,112 22.0%
APG Asset Management NV 6,605,810 5.01%
Baillie Gifford & Co. 4,643,180 3.52%
The Vanguard Group, Inc. 2,753,460 2.09%
Walter Scott & Partners Ltd. 2,315,762 1.76%
Norges Bank Investment Management 2,044,399 1.55%
BlackRock Fund Advisors 2,000,450 1.52%
Morgan Stanley Investment Management Co. 1,743,841 1.32%
GuardCap Asset Management Ltd. 1,720,260 1.30%
Morgan Stanley Investment Management, Inc. 1,557,920 1.18%
Holdings
NameEquities%Valuation
CHR. HANSEN HOLDING A/S (CHR) 182,523 0.14% 11,893,485 USD
Markets and indexes
- Main Market Large
- OMX Copenhagen 25 / NASDAQ OMX Nordic 120, PEA, STOXX Europe 600
Stock Exchange Codes
- Bloomberg Code :  CHR:DC
- Reuters Code :  CHR.CO
- Datastream Code :  
Company contact information
Chr. Hansen Holding A/S
Boege AllÚ 10-12
DK-2970 H°rsholm, Hovedstaden

Phone : +45 45 74 74 74
Fax : +45 45 74 88 88
web site : https://www.chr-hansen.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Chr. Hansen Holding A/S